8YY: Embracing Future Holdings Limited - Summary | Jitta

Embracing Future Holdings Limited

SGX:8YY

Price
S$0.05
Loss Chance
57.9%
1.61JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
303 / 499
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (56)
Financial Strength (27)
Return to Shareholders (0)
Competitive Advantage (38)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 63.49% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.61
100.00%
3.59
431.01%
Health Care Equipment
2.67
715.27%
2.41
100.00%
COMPANY DESCRIPTION
Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also engages in technology development, technology transfer, marketing, sale and distribution of biomedical technology, life and medicine science related products and services, integrated marketing services provider in the gaming industry, multi-channel networking and live-streaming and investment activities. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. Embracing Future Holdings Limited was incorporated in 2009 and is based in Singapore.